Phenylketonuria News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phenylketonuria. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phenylketonuria Today - Breaking & Trending Today

Synlogic pulls plug after peek at phenylketonuria phase III data

Synlogic Inc. jolted Wall Street with news that the firm is scrapping for futility Synpheny-3, its pivotal study with labafenogene marselecobac (SYNB-1934) for phenylketonuria, and will evaluate strategic options. Shares of the Cambridge, Mass.-based firm (NASDAQ:SYBX) fell 48.7%, or $1.68, to end Feb. 9 at $1.77. Synlogic will cease operations and reduce its workforce by more than 90%, retaining only certain employees to help with the wind-down. ....

United Kingdom , Synlogic Inc , Wall Street , Synlogic Inc , Labafenogene Marselecobac , Synb 1934 , Endocrine Metabolic ,

Next-generation genome editing tools surpass CRISPR milestone

Modifying a patient’s DNA is no longer just for science fiction novels. The CRISPR gene editing technique developed by Jennifer Doudna and Emmanuelle Charpentier only took 10 years to reach the market as Casgevy (exagamglogene autotemcel/exa-cel, Vertex Pharmaceuticals Inc.), treating congenital pathologies such as β-thalassemia and severe sickle cell disease (SCD). But science does not stop. ....

Jennifer Doudna , Emmanuelle Charpentier , Vertex Pharmaceuticals Inc , Sickle Cell Disease , Spinal Muscular Atrophy , Base Editing , Prime Editing ,

Gene editing breakthrough could offer new hope for people with phenylketonuria

Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals' genetic ancestry. PKU causes an amino acid-;called phenylalanine (Phe)-;to build up in the bloodstream. ....

United States , University Of Pennsylvania , Kiran Musunuru , Lily Ramsey , Rebeccac Ahrens Nicklas , American Society Of Human Genetics , Perelman School Of Medicine , National Institutes Of Health , Perelman School , American Journal , Human Genetics , Genomics Advances , American Society , Dominique Brooks , Cardiovascular Medicine , National Institutes , Amino Acid , Covid 19 , Gene Editing ,

Penn Medicine and CHOP receive $26 million NIH grant to develop treatments for three rare genetic diseases

A Penn Medicine and Children's Hospital of Philadelphia (CHOP) team will seek to develop treatments for three rare, incurable genetic diseases with the help of a $26 million grant from the National Institutes of Health (NIH). ....

United States , Kiran Musunuru , William Peranteau , Lily Ramsey , Epigenetic Origins Of Disease Program , National Institutes Of Health , Cardiovascular Institute At Penn , Penn Center , Genetics In Penn Perelman School Of Medicine , Penn Medicine , National Institutes , Cardiovascular Medicine , Perelman School , Inherited Cardiovascular Disease , Epigenetic Origins , Disease Program , Cardiovascular Institute , Fetal Diagnosis , Adzick Mccausland Distinguished Chair , Amino Acid , Genetic Disorder , Rare Disease , Tyrosinemia Type 1 , Vision Loss ,

WHO Says Aspartame Possibly Carcinogenic To Humans, But Safe Within Limits

WHO has classified non-sugar or artificial sweetener Aspartame as possibly carcinogenic but safe for humans when consumed within limits, which is the daily intake of 40 milligrams per kilogram of a person’s body weight. , Health News, Times Now ....

New Delhi , Mary Schubauer Berigan , Research On Cancer , International Agency , Monographs Programme , Expert Committee On Food Additives , Committee On Food Additives , Food And Agricultural Organisation , World Health Organisation , Joint Committee , Food Additives , International Agency For Research , Food And Agricultural , Coca Cola India Vice President , Joint Expert Committee , International Agency For Research On Cancer , Food And Agricultural Organisation , Mary Schubauer Berigan , Food Additives , Artificial Sweetener , Health News , Imes Now ,